Programme 2020


View Programme



Chair’s opening remarks

Oli Hudson, Content Director, Wilmington Healthcare 


Assessing the UK Life Science sector response to COVID-19: Lessons, challenges and future opportunities

  • Gain insight into how intelligent collaboration across the ecosystem has accelerated R&D and find out where we are in terms of product development
  • Learn what further opportunities there are for pharma to strengthen its response to the pandemic
  • Understand what the post-pandemic era will look like for pharma and find out what contingency plans you need to consider to adapt to the new normal
  • What lessons can be learned from international approaches? Can we create the knowledge and capability to support a future UK response to a pandemic should it occur?


Nicole Mather, Non-Executive Director, NHS Health Research Authority


Live Q&A


Short break and session change


Shifting from supplier to partner: Strengthening collaboration between pharma and the NHS

  • Gain insight into the main concerns of healthcare professionals and understand what more you can do to meet their changing needs
  • Find out what long-term impacts virtual working will have on patients, healthcare professionals and industry
  • Gain practical insight and specific strategies for maintaining open lines of communication with NHS stakeholders
  • Learn why you need to reshape your value proposition across the entire healthcare ecosystem and align with key principles that underpin the NHS Long Term Plan to become more commercially attractive


James Roach, Director of West Essex One Health and Care Partnership and Founder of Conclusio

Anthony Mckeever, Interim Executive Lead, Mid and South Essex Health and Care Partnership & Joint Accountable Officer for its 5 CCGs


Live Q&A


Short break and session change


Industry’s gateway to the NHS: Reducing time to market by breaking down barriers to innovation and adoption

  • Learn what regulatory flexibilities have been introduced to fast-track market access for industry - how can we ensure that regulators are listening to industry?
  • Assess the main barriers to uptake of innovation and identify the most appropriate routes to NHS access
  • Understand how you can maintain market access continuity through the global pandemic
  • Hear how the Accelerated Access Collaborative (AAC) will support rapid uptake of new products and sustainable long-term market access post-COVID-19


Matthew Whitty, Interim Director of Innovation, Research and Life Sciences & Interim Chief Executive of the Accelerated Access Collaborative, NHS England and NHS Improvement


Live Q&A


Short break and session change


Horizon Scanning: Building long-term resilience into the supply chain for the future

  • Understand the importance of bringing more drug manufacturing to the UK to reduce the risk of future shortages and supply disruption
  • How we can ensure the UK remains an attractive location for manufacturing innovation as well as for skilled workers to undertake research and development
  • Gain insight into potential pressures on global supply chains due to the impact of COVID-19. Find out what is being done to ensure supply chains become robust and resilient in the long-term


Steve Oldfield, Chief Commercial Officer, Department of Health and Social Care

Dr Layla McCay, Director of International Relations, NHS Confederation


Live Q&A


Chair’s closing remarks

Oli Hudson, Content Director, Wilmington Healthcare




To book your place, visit our website or contact Ryan Bessent at +44(0)20 7608 9045
​or for more information


By continuing to use the site you agree to our cookies policy. Accept